Precedex Versus Propofol-Awakening for Reducing Brain Injury Expansion
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate brain injury when two different drugs (propofol and
precedex) are used to sedate patients who need a neurologic exam.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Carmelo Graffagnino
Collaborators:
Hospira, Inc. Hospira, now a wholly owned subsidiary of Pfizer